ArticleWorld journal of surgical oncology2025
Relationship between preoperative body mass index and overall mortality in patients who have undergone lobectomy for lung cancer.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimsPreoperative body mass index (BMI) has been shown to be an important prognostic factor after lobectomy in patients with lung cancer. However, few studies have investigated the relationship between preoperative BMI and overall mortality in these patients. In this study, we aimed to identify the range of BMI that heralds a favorable prognosis in patients who have undergone lobectomy for lung cancer.
methodsThe association between BMI and overall survival was examined using primary data from an affiliated hospital database and fitted adjusted Cox regression models. The restricted cubic spline (RCS) method was used to report the relationship between preoperative BMI and overall mortality. Fully adjusted models were stratified by and adjusted for sex, age, disease stage, respiratory function, and adjuvant chemotherapy.
resultsOf 3307 patients identified to have undergone radical resection of lung cancer between November 2009 and July 2019, 2365 underwent lobectomy and 558 died. BMI had a J-shaped association with overall mortality; we estimated that the overall mortality risk reached a nadir at BMI values of 23.2-29.4, with an inverse association below 23.2 (hazard ratio 0.104 per 5-unit decrease; 95% confidence interval 0.089-0.119), a positive association above 29.4 (hazard ratio 0.022 per 5-unit increase; 95% confidence interval 0.004-0.040), and the lowest mortality at 25.7.
conclusionPreoperative BMI is an important prognostic factor after lobectomy in patients with lung cancer. A BMI of 23.2-29.4 has a prognostic benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.